| Workshops and Panel Presentations |
|
Enhancing Access to Prescription Drug Monitoring Programs Through Health Information Technology
Tuesday, April 10, 2012, 1:00 pm – 2:00 pm |
| Moderator |
Christopher M. Jones, Pharm.D., MPH, LCDR U.S. Public Health Service |
| Presenters |
Jinhee Lee, PharmD, Public Health Advisor, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; and Hon. Kate Tipping, Policy Analyst, Office of the National Coordinator for Health Information Technology |
| Panel Description |
Prescription Monitoring Programs (PMP) collect data on various controlled substance prescriptions on a statewide basis and enable prescribers, pharmacists, regulatory boards and law enforcement agencies (under certain restrictions) to access this information pursuant to applicable state guidelines. Additionally, PMPs may aid the care of those patients with chronic, untreated pain or chemical dependency and help to identify patients engaged in prescription drug abuse and diversion. PMPs can be especially helpful to prescribers treating patients with substance-related disorders.
In this workshop, presenters will describe PMPs and the role of PMPs as an assessment and monitoring tool for health care providers as well as information about a government initiative that aims to use health information technology to enhance access to PMPs. |
| Learning Objectives |
1. Explain the purpose and scope of Prescription Monitoring Programs.
2. Outline Prescription Monitoring Programs as an additional tool in the management of patients with substance-related disorders.
3. Describe details about a current government initiative that aims to enhance access to Prescription Monitoring Programs. |
|
What Every Prescriber and Pharmacist Needs to Know About Addiction
Tuesday, April 10, 2012, 2:15 pm – 3:45 pm |
| Moderator |
Christopher M. Jones, Pharm.D., MPH, LCDR U.S. Public Health Service |
| Presenters |
Dr. Elinore F. McCance-Katz, MD, PhD, Professor of Psychiatry, University of California San Francisco; and Mr. Peter VanPelt, Associate Director, Corporate Alliances, American Pharmacists Association (APA) |
| Session Description |
Prescribers and pharmacists in all practice settings see patients with pain complaints on a regular basis. They are often faced with patients who are seeking opioids for non-medical purposes. When this happens, prescribers and pharmacists are challenged to differentiate patients who are seeking opioids for pain relief and those who intend to misuse, abuse, or divert the medications. They are well positioned to identify patients whose pain is undertreated, as well as those who have signs and symptoms of opioid addiction. Many patients are unaware of treatment options available for opioid addiction; prescribers and pharmacists can identify patients who may benefit from such treatment and make appropriate referrals.
This session will provide an overview of the neuropharmacology and neuroanatomy of addiction in understandable terms, provide information on how to identify traits of individuals seeking opioids for non-medical purposes, and outline steps that can/should be taken to deal with these situations. Participants will garner a better understanding of factors influencing how addiction is perceived and addressed. |
| Learning Objectives |
1. Describe behavioral traits that can be used to identify potential addicts and/or those engaged in drug diversion.
2. Explain the role of prescribers and pharmacists in opioid addiction intervention, support and treatment.
3. Identify ways for prescribers and pharmacists to differentiate between chronic pain patients maintained on opioids and individuals addicted to opioids. |
|
What Every Clinician Needs to Know About Overdoses
Tuesday, April 10, 2012, 4:00 pm – 5:30 pm |
| Moderator |
Dr. Nathaniel P. Katz, MD, MS, President & CEO, Alalgesic Solutions; Adjunct Assistant Professor of Anesthesia, Tufts University School of Medicine |
| Presenters |
Erin Johnson, MPH, Manager, Prescription Pain Medication Program, Utah Department of Health; and Dr. Henry Spiller, Fellow of the American Academy of Clinical Toxicology, Director, Kentucky Regional Poison Control Center |
| Session Description |
Over the past 14 years there has been a 600 percent increase in the number of hospital admissions for opiate overdoses and a corresponding rise of in-patient health care costs. This session examines temporal trends, substances involved, geographic trends and changes in medical outcomes.
Data collected from a Utah Department of Health investigation sheds light on the characteristics and behaviors of individuals who died from an unintentional, prescription opioid overdose. Learn about the characteristics and risk factors that may predispose patients to an overdose and how education efforts can incorporate these findings. The presentation will also discuss the use of US Poison Control Center data as a public health surveillance tool to help monitor prescription drug diversion. |
| Learning Objectives |
1. Describe the correlation between prescription drug abuse and the rate of opioid-related overdose deaths (accidental and deliberate) and hospital admissions.
2. Describe the characteristics and risk factors that may predispose patients to an overdose.
3. State the value of Poison Control Center data in formulating strategies to reduce prescription drug diversion health care associated problems. |
|
Safe Prescribing and Use of Opioids Panel Discussion
Wednesday, April 11, 2012, 11:15 am – 12:30 pm |
| Moderator |
Dr. Nathaniel P. Katz, MD, MS, President & CEO, Alalgesic Solutions; Adjunct Assistant Professor of Anesthesia, Tufts University School of Medicine |
| Panelists |
Dr. Daniel P. Alford, MD, MPH, FACP, FASAM, Associate Professor of Medicine, Assistant Dean for Continuing Medical Education, and Program Director of the Addiction Medicine Fellowship Program, Boston University School of Medicine, and President-elect, Association of Medical Education in Research in Substance Abuse (AMERSA); Sarah Ball, PharmD, Assistant Professor, South Carolina College of Pharmacy of the Medical University of South Carolina and the University of South Carolina; and Dr. Benjamin C. Lok, PhD, Associate Professor, Department of Computer and Information Sciences and Engineering, University of Florida |
| Panel Description |
Properly managed medical use of opioid analgesic compounds are safe and effective for treatment in chronic non-cancer pain patients. But physicians and other health care providers need to be aware of issues that lead to misuse and abuse. Discussion will include when to initiate treatment, difference in treatment for specific populations, management of opioid misuse and addiction, and careful prescribing to limit potential harms. An overview of current evidence-based professional education programs (both in-person and web-based) and promising new programs under development will be provided. |
| Learning Objectives |
1. Analyze current professional education programs on safe use of opioids and new programs under development.
2. Explain a potentially transformative on-line educational tool for health professionals that enable them to train by interacting with “virtual patients.”
3. Describe a Massachusetts program for training physicians on safe opioid prescribing, and the curriculum developed to teach residents and faculty. |
|
Opioid Dependence: Health Plan Problems and Strategies
Wednesday, April 11, 2012, 1:30 pm – 3:00 pm |
| Moderator |
Peter VanPelt, RPh, Associate Director, Corporate Alliances, American Pharmacists Association (APA) |
| Presenters |
Dr. Kelly J. Clark, MD, MBA, DFAPA, Medical Director, Behavioral Health, Capital District Physicians’ Health Plan (CDPHP); and Dr. Nathaniel P. Katz, MD, MS, President & CEO, Analgesic Solutions, Adjunct Assistant Professor of Anesthesiology, Tufts University School of Medicine, and former Chair of FDA Advisory Committee on Anesthesia, Critical Care and Addiction Products |
| Session Description |
Prescription drug abusers don’t rely solely on the street-level dealer to obtain their medications. Doctor offices, emergency rooms, pain clinics, and diversion also are key links in the supply chain. Physicians face barriers in adhering to narcotics guidelines. Learn what these barriers are and what actions can be taken to overcome them. Discussion will include clinical integration of behavioral health and medical management.
In this session, learn best practice recommendations for medical providers, review of mechanisms for prescription drug diversion, and implications of these findings. Topics include case management outreach, case coordination, and encouraging cooperative care between providers and facilities. Examples of innovative programs to improve quality and decrease cost of care will also be presented. |
| Learning Objectives |
1. Identify barriers to responsible pain management that does not contribute to an addiction or to diversion activities.
2. Outline best practice strategies for patient monitoring to prevent over-prescribing and dispensing.
3. Explain the importance of coordinating care between health care providers and facilities.
|
|
Responsible Prescribing Practices
Wednesday, April 11, 2012, 3:15 pm – 4:45 pm |
| Moderator |
Christopher M. Jones, Pharm.D., MPH, LCDR U.S. Public Health Service |
| Presenters |
Dr. Rollin M. Gallagher, MD, MPH, Deputy National Program Director for Pain Management, Veterans Health Administration, Co-Chair, Pain Management Work Group, Veterans Administration-DoD Health Executive Council; Dr. Andrew Kolodny, MD, President, Physicians for Responsible Opioid Prescribing (PROP), Chairman, Department of Psychiatry, Maimonides Medical Center; and Robert Sproul, PharmD, Director, OVAMC Pain Management Program, Director, Pharmacy Pain Management & Palliative Care Project, Co-Chair, Veterans Administration National Pain Management Pharmacy Work Group |
| Session Description |
High dose opioid prescribing is a dangerous practice. Cautious, safe and responsible prescribing is essential. This session will include a discussion on identifying misinformation about opioid prescribing. A physician’s perspective on practical reasons for greater diligence will be shared along with how effective strategies reduce the risk of morbidity and mortality.
The Pharmacy Benefits Management Services of the Department of Veterans Affairs will provide perspective from a large health systems perspective with emphasis on commitment to evidence-based practice and policy. Specific categories to be discussed include provider education (web-based and “boot camps”), patient education, and quality improvement and control, as well as operations to minimize risk and diversion through interactions with other agencies. Clinical practice guidelines for chronic pain will also be shared. |
| Learning Objectives |
1. Describe how cautious, evidence-based prescribing practices can lower opioid-related overdose deaths while maintaining appropriate access for medically needed treatment of chronic pain.
2. Identify “best practice” strategies that can be used by clinicians for pain management treatment.
3. Explain evidence-based practice and policies for provider education and patient education programs being utilized across the U.S. |
|
